Prediction of cardiac complications after liver transplantation

Transplantation

Volumn 87, Issue 5, 2009, Pages 763-770

  Fouad, Tamer R ^a,b   Abdel Razek, Wael M ^b   Burak, Kelly W ^a   Bain, Vincent G ^c   Lee, Samuel S ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b MENOUFIA UNIVERSITY   (Egypt)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Cardiac complications; Cardiovascular; Integrated MELD; Mortality; Transplant

Indexed keywords

ADULT; AGED; ARTICLE; DISEASE SEVERITY; FEMALE; HEART ARRHYTHMIA; HEART ATRIUM THROMBOSIS; HEART DISEASE; HEART FAILURE; HEPATITIS C; HUMAN; INTEGRATED MODEL FOR END STAGE LIVER DISEASE; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; PERICARDIAL EFFUSION; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RISK FACTOR; SCORING SYSTEM; CAUSE OF DEATH; CHEMICALLY INDUCED DISORDER; CLASSIFICATION; ELECTROCARDIOGRAPHY; HOSPITALIZATION; LIVER DISEASE; MIDDLE AGED; MORTALITY; PEROPERATIVE COMPLICATION; POSTOPERATIVE COMPLICATION; PREDICTION AND FORECASTING; PREOPERATIVE CARE; RETROSPECTIVE STUDY; THORAX RADIOGRAPHY;

ADULT; AGED; CAUSE OF DEATH; ELECTROCARDIOGRAPHY; FEMALE; HEART DISEASES; HUMANS; INTRAOPERATIVE COMPLICATIONS; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; RADIOGRAPHY, THORACIC; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 65649098010     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318198d734     Document Type: Article

References (55)

1. Dec GW, Kondo N, Farrell ML, et al. Cardiovascular complications following liver transplantation. Clin Transplant 1995; 9: 463.
2. Johnston SD, Morris JK, Cramb R, et al. Cardiovascular morbidity and mortality after orthotopic liver transplantation. Transplantation 2002; 73: 901.
3. Therapondos G, Flapan AD, Plevris JN, et al. Cardiac morbidity and mortality related to orthotopic liver transplantation. Liver Transpl 2004; 10: 1441.
4. Therapondos G, Flapan AD, Dollinger MM, et al. Cardiac function after orthotopic liver transplantation and the effects of immunosuppression: A prospective randomized trial comparing cyclosporin (neoral) and tacrolimus. Liver Transpl 2002; 8: 690.
5. Plevak DJ, Southorn PA, Narr BJ, et al. Intensive-care unit experience in the Mayo liver transplantation program: The first 100 cases. Mayo Clin Proc 1989; 64: 433.
6. Snowden CP, Hughes T, Rose J, et al. Pulmonary edema in patients after liver transplantation. Liver Transpl 2000; 6: 466.
7. Donovan CL, Marcovitz PA, Punch JD, et al. Two-dimensional and dobutamine stress echocardiography in the preoperative assessment of patients with end-stage liver disease prior to orthotopic liver transplantation. Transplantation 1996; 61: 1180.
8. Rabkin JM, de La Melena V, Orloff SL, et al. Late mortality after orthotopic liver transplantation. Am J Surg 2001; 181: 475.
9. Clavien PA, Camargo CA Jr, Croxford R, et al. Definition and classification of negative outcomes in solid organ transplantation. Application in liver transplantation. Ann Surg 1994; 220: 109.
10. Abbasoglu O, Levy MF, Brkic BB, et al. Ten years of liver transplantation: An evolving understanding of late graft loss. Transplantation 1997; 64: 1801.
11. Pruthi J, Medkiff KA, Esrason KT, et al. Analysis of causes of death in liver transplant recipients who survived more than 3 years. Liver Transpl 2001; 7: 811.
12. Neuberger J. Liver transplantation. J Hepatol 2000; 32(1 suppl): 198.
13. Piscaglia F, Zironi G, Gaiani S, et al. Systemic and splanchnic hemodynamic changes after liver transplantation for cirrhosis: A long-term prospective study. Hepatology 1999; 30: 58.
14. Navasa M, Feu F, Garcia-Pagan JC, et al. Hemodynamic and humoral changes after liver transplantation in patients with cirrhosis. Hepatology 1993; 17: 355.
15. Myers RP, Lee SS. Cirrhotic cardiomyopathy and liver transplantation. Liver Transpl 2000; 6: S44.
16. Ma Z, Lee SS. Cirrhotic cardiomyopathy: Getting to the heart of the matter. Hepatology 1996; 24: 451.
17. Moller S, Henriksen JH. Cirrhotic cardiomyopathy: A pathophysiological review of circulatory dysfunction in liver disease. Heart 2002; 87: 9.
18. Alqahtani SA, Fouad TR, Lee SS. Cirrhotic cardiomyopathy. Semin Liver Dis 2008; 28: 59.
19. Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31: 864.
20. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464.
21. Wiesner RH, Edwards E, Freeman R, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003; 124: 91.
22. Biggins SW, Kim WR, Terrault NA, et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology 2006; 130: 1652.
23. Luca A, Angermayr B, Bertolini G, et al. An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis. Liver Transpl 2007; 13: 1174.
24. Jolles H, Henry DA, Coppage L, et al. Critical care imaging of the chest. In: Grenvik A, Ayres SM, Holbrook PR, et al., eds. Textbook of critical care, [ed. 4]. Philadelphia, Saunders 2000, pp 397.
25. Thomason JW, Ely EW, Chiles C, et al. Appraising pulmonary edema using supine chest roentgenograms in ventilated patients. Am J Respir Crit Care Med Res Rev 1998; 157: 1600.
26. Acosta F, Sabaté A. Post-reperfusion syndrome in orthotopic liver transplantation. Rev Esp Anestesiol Reanim 1996; 43: 276.
27. Aggarwal S, Kang Y, Freeman JA, et al. Postreperfusion syndrome: Cardiovascular collapse following hepatic reperfusion during liver transplantation. Transplant Proc 1987; 119(suppl 3): 54.
28. Ramsay MA, Simpson BR, Nguyen AT, et al. Severe pulmonary hypertension in liver transplant candidates. Liver Transpl Surg 1997; 3: 494.
29. Krowka MJ, Plevak DJ, Findlay JY, et al. Pulmonary hemodynamics and perioperative cardio-pulmonary mortality in patients with portopulmonary hypertension undergoing liver transplantation. Liver Transpl 2000; 6: 443.
30. Burra P, Graziotto A, Senzolo M, et al. Myocardial perfusion scintigraphy in patients with liver cirrhosis evaluated for orthotopic liver transplantation. Transplant Proc 2001; 33: 1447.
31. Zoghbi GJ, Patel AD, Ershadi RE, et al. Usefulness of preoperative stress perfusion imaging in predicting prognosis after liver transplantation. Am J Cardiol 2003; 92: 1066.
32. Cazzaniga M, Salerno F, Pagnozzi G, et al. Diastolic dysfunction is associated with poor survival in patients with cirrhosis with transjugular intrahepatic portosystemic shunt. Gut 2007; 56: 869.
33. Eagle KA, Brundage BH, Chaitman BR, et al. Guidelines for perioperative cardiovascular evaluation for noncardiac surgery. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol 1996; 27: 910.
34. Eagle KA, Berger PB, Calkins H, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery - Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol 2002; 39: 542.
35. Baik SK, Fouad TR, Lee SS. Cirrhotic cardiomyopathy. Orphanet J Rare Dis 2007; 2: 15.
36. Freeman RB, Rohrer RJ, Katz E, et al. Preliminary results of a liver allocation plan using a continuous medical severity score that deemphasizes waiting time. Liver Transpl 2001; 7: 173.
37. Saab S, Wang V, Ibrahim AB, et al. MELD score predicts 1-year patient survival post-orthotopic liver transplantation. Liver Transpl 2003; 9: 473.
38. Akyildiz M, Karasu Z, Arikan C, et al. Impact of pretransplant MELD score on posttransplant outcome in living donor liver transplantation. Transplant Proc 2004; 36: 1442.
39. Buenadicha AL, Martín LG, Martín EE, et al. Assessment of short-term survival after liver transplant by the model for end-stage liver disease. Transplant Proc 2005; 37: 3881.
40. Yoo HY, Thuluvath PJ. Short-term postliver transplant survival after the introduction of MELD scores for organ allocation in the United States. Liver Int 2005; 25: 536.
41. Wang VS, Saab S. Liver transplantation in the era of model for endstage liver disease. Liver Int 2004; 24: 1-8 Review.
42. Huo TI, Wang YW, Yang YY, et al. Model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor and its correlation with portal pressure in patients with liver cirrhosis. Liver Int 2007; 27: 498.
43. Biggins SW, Rodriguez HJ, Bacchetti P, et al. Serum sodium predicts mortality in patients listed for liver transplantation. Hepatology 2005; 41: 32.
44. Wong VW, Chim AM, Wong GL, et al. Performance of the new MELD-Na score in predicting 3-month and 1-year mortality in Chinese patients with chronic hepatitis B. Liver Transpl 2007; 13: 1228.
45. Young AL, Rajagenashan R, Asthana S, et al. The value of MELD and sodium in assessing potential liver transplant recipients in the United Kingdom. Transpl Int 2007; 20: 331.
46. Ruf AE, Kremers WK, Chavez LL, et al. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone. Liver Transpl 2005; 11: 336.
47. De Jongh FE, Janssen HL, de Man RA, et al. Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver. Gastroenterology 1992; 103: 1630.
48. Gine's P, Quintero E, Arroyo V, et al. Compensated cirrhosis: Natural history and prognostic factors. Hepatology 1987; 7: 122.
49. Schlichting P, Christensen E, Andersen PK, et al. Prognostic factors in cirrhosis identified by Cox's regression model. Hepatology 1983; 3: 889.
50. Pozzi M, Carugo S, Boari G, et al. Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites. Hepatology 1997; 26: 1131.
51. Torregrosa M, Aguade S, Dos L, et al. Cardiac alterations in cirrhosis: Reversibility after liver transplantation. J Hepatol 2005; 42: 68.
52. Wong F, Girgrah N, Graba J, et al. The cardiac response to exercise in cirrhosis. Gut 2001; 49: 268.
53. Flach R, Speidel N, Flohe S, et al. Analysis of intragraft cytokine expression during early reperfusion after liver transplantation using semiquantitative RT-PCR. Cytokine 1998; 10: 445.
54. Mueller AR, Platz KP, Haak M, et al. The release of cytokines, adhesion molecules, and extracellular matrix parameters during and after reperfusion in human liver transplantation. Transplantation 1996; 62: 1118.
55. Bellamy MC, Galley HF, Webster NR. Changes in inflammatory mediators during orthotopic liver transplantation. Br J Anaesth 1997; 79: 338.